Table 3.
Comparison of diagnostic performance of US, CEUS, and US + CEUS for SLN status.
Methods | Sen | Spe | PPV | NPV | AUC (95% CI) |
---|---|---|---|---|---|
US *,# | 70.67% (53/75) | 77.68% (87/112) | 67.95% (53/78) | 79.82% (87/109) | 0.742 (0.677–0.806) |
CEUS & | 82.67% (62/75) | 80.36% (90/112) | 73.81% (62/84) | 87.38% (90/103) | 0.815 (0.758–0.872) |
US + CEUS | 86.67% (65/75) | 77.68% (87/112) | 72.22% (65/90) | 89.69% (87/97) | 0.822 (0.767–0.876) |
SLN = Sentinel lymph node, US = Ultrasound, CEUS = Contrast-enhanced ultrasound, Sen = Sensitivity, Spe = Specificity, PPV = Positive predictive value, NPV = Negative predictive value, AUC = area under the curve, CI = Confidence interval. Note: * indicates p = 0.005 compared with the CEUS group; # indicates p < 0.001 compared with the CEUS + US group; & indicates p = 0.630 compared with the US + CEUS group.